Microbot Medical Inc.
MBOT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $147 | $92 | $26 | $19 |
| - Cash | $7 | $4 | $3 | $3 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $141 | $88 | $23 | $16 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$4 | -$3 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.074 | -0.096 | 0.006 | -0.2 |
| % Growth | 22.4% | -1,672.1% | 103.1% | – |
| Operating Cash Flow | -$4 | -$3 | -$3 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$3 | -$3 | -$2 |